Brentuximab Vedotin Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of brentuximab vedotin that may be used in the treatment of diffuse large B-cell lymphoma (DLBCL), Hodgkin lymphoma (HL), T-cell lymphoma, primary cutaneous CD30+ T-cell lymphoproliferative disorders, and mycosis fungoides/Sezary syndrome.

**Synonyms:** - Adcetris Regimen - Brentuximab vedotin monotherapy